Literature DB >> 15875210

The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training.

Nathan K LeBrasseur1, Kelly C Mizer, Jascha D Parkington, Douglas B Sawyer, Roger A Fielding.   

Abstract

The neuregulin/erbB-signaling axis contributes to the development and growth of multiple mammalian tissues including skeletal muscle. In this study, we sought to characterize the native expression of this system in human skeletal muscle and test the hypothesis that a program of progressive resistance training (PRT) would regulate the expression of neuregulin (NRG) and its cognate receptors. Twelve healthy-male subjects underwent 8-weeks of lower-extremity PRT and muscle biopsies were performed at baseline and following 1- and 8-weeks of the intervention. PRT resulted in significant gains in skeletal muscle strength without appreciable changes in fiber size or myosin heavy chain (MHC) composition. At baseline, Western Blot analysis demonstrated expression of erbB2, erbB3 and erbB4 receptors and multiple NRG isoforms. Following 1- and 8-weeks of PRT, no changes erbB2, erbB4 or NRG expression were observed. ErbB3 expression, however, was significantly increased at both time points compared to baseline. Double labeling of muscle cross-sections revealed increased expression of erbB3 following PRT was not exclusive to fibers staining positive for MHC IIa. Thus, erbB2, erbB3, erbB4 and multiple NRG isoforms are natively expressed in human skeletal muscle. Following PRT, a significant increase in erbB3 was observed. The ability to detect basal expression and alterations in response to physiologic stimuli merit further studies examining the role of this system in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875210     DOI: 10.1007/s00421-005-1333-4

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  24 in total

1.  A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells.

Authors:  E Suárez; D Bach; J Cadefau; M Palacin; A Zorzano; A Gumá
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

2.  Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-alpha-converting enzyme.

Authors:  J C Montero; L Yuste; E Díaz-Rodríguez; A Esparís-Ogando; A Pandiella
Journal:  Mol Cell Neurosci       Date:  2000-11       Impact factor: 4.314

3.  The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain.

Authors:  J Y Wang; S J Miller; D L Falls
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

4.  Neuregulin stimulates myogenic differentiation in an autocrine manner.

Authors:  D Kim; S Chi; K H Lee; S Rhee; Y K Kwon; C H Chung; H Kwon; M S Kang
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

5.  ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

Authors:  N J Hellyer; K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

6.  High-velocity resistance training increases skeletal muscle peak power in older women.

Authors:  Roger A Fielding; Nathan K LeBrasseur; Anthony Cuoco; Jonathan Bean; Kelly Mizer; Maria A Fiatarone Singh
Journal:  J Am Geriatr Soc       Date:  2002-04       Impact factor: 5.562

7.  The transmembrane heregulin precursor is functionally active.

Authors:  Z Aguilar; D J Slamon
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

8.  Requirement for neuregulin receptor erbB2 in neural and cardiac development.

Authors:  K F Lee; H Simon; H Chen; B Bates; M C Hung; C Hauser
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

9.  The erbB3 gene product is a receptor for heregulin.

Authors:  K L Carraway; M X Sliwkowski; R Akita; J V Platko; P M Guy; A Nuijens; A J Diamonti; R L Vandlen; L C Cantley; R A Cerione
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

10.  ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.

Authors:  E Tzahar; G Levkowitz; D Karunagaran; L Yi; E Peles; S Lavi; D Chang; N Liu; A Yayon; D Wen
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

View more
  12 in total

Review 1.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?

Authors:  Douglas B Sawyer; Xuyang Peng; Billy Chen; Laura Pentassuglia; Chee Chew Lim
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

Review 2.  Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.

Authors:  Jessica M Scott; Aarif Khakoo; John R Mackey; Mark J Haykowsky; Pamela S Douglas; Lee W Jones
Journal:  Circulation       Date:  2011-08-02       Impact factor: 29.690

Review 3.  Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Authors:  Emily M Parodi; Bernhard Kuhn
Journal:  Cardiovasc Res       Date:  2014-01-29       Impact factor: 10.787

4.  Exercise training and return to a well-balanced diet activate the neuregulin 1/ErbB pathway in skeletal muscle of obese rats.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Maude Gerbaix; Lore Metz; Monique Etienne; Stéphane Walrand; Aurélie Masgrau; Christelle Guillet; Daniel Courteix; Airu Niu; Yi-Ping Li; Fréderic Capel; Pascal Sirvent
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

5.  High ErbB3 activating activity in human blood is not due to circulating neuregulin-1 beta.

Authors:  Emmanuel Boateng; Joanne T deKay; Sarah M Peterson; Jacob Boles; Nathan Pinnette; Mary W Sorcher; Michael P Robich; Douglas B Sawyer; Sergey Ryzhov
Journal:  Life Sci       Date:  2020-04-03       Impact factor: 5.037

6.  Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Stephen E Kimmel; Radwan N Safa; Mary E Putt; Nancy K Sweitzer; James C Fang; Douglas B Sawyer; Thomas P Cappola
Journal:  Circulation       Date:  2009-07-13       Impact factor: 29.690

7.  Serum Neuregulin-1beta as a Biomarker of Cardiovascular Fitness.

Authors:  Vaibhav Moondra; Satyam Sarma; Tracy Buxton; Radwan Safa; Gregory Cote; Thomas Storer; Nathan K Lebrasseur; Douglas B Sawyer
Journal:  Open Biomark J       Date:  2009

Review 8.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

Review 9.  Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.

Authors:  Virginia Shalkey Hahn; Daniel J Lenihan; Bonnie Ky
Journal:  J Am Heart Assoc       Date:  2014-04-22       Impact factor: 5.501

10.  Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.

Authors:  Gerard Hoyne; Caroline Rudnicka; Qing-Xiang Sang; Mark Roycik; Sarah Howarth; Peter Leedman; Markus Schlaich; Patrick Candy; Vance Matthews
Journal:  BMC Cancer       Date:  2016-02-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.